Literature DB >> 8219822

Depression and its treatment in cardiac patients.

F Fernandez1.   

Abstract

In general medical-surgical hospital services, depression is the most common reason for seeking psychiatric consultation in behalf of patients with cardiovascular disease. The nontreatment of depression or the use of a psychotropic agent mismatched to a patient's particular cardiac condition or individual sensitivities has considerable negative impact. Therefore, a systematic approach should be used in the differential diagnosis of depression in cardiac patients, to eliminate other psychiatric disorders and to assure the correct treatment strategy. Physicians can develop an appropriate rationale for the use of a psychopharmacologic regimen in cardiovascular settings through recognition of the diagnostic criteria for depression and through comprehensive knowledge of the pharmacologic properties and possible cardiovascular effects of these vital treatments. Standard and alternative pharmacotherapies for depression in cardiac patients are reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219822      PMCID: PMC325091     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  41 in total

1.  Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease.

Authors:  R Pohl; M Bridges; J M Rainey; H Boudoulas; V K Yeragani
Journal:  J Clin Psychopharmacol       Date:  1986-12       Impact factor: 3.153

Review 2.  Treatment of the cardiac-impaired depressed patient. Part II: Lithium, carbamazepine, and electroconvulsive therapy.

Authors:  L B Guttmacher; M G Goldstein
Journal:  Psychiatr Med       Date:  1988

Review 3.  Treatment of the cardiac-impaired depressed patient. Part I: General considerations, heterocyclic antidepressants, and monoamine oxidase inhibitors.

Authors:  M G Goldstein; L B Guttmacher
Journal:  Psychiatr Med       Date:  1988

4.  The nature and course of depression following myocardial infarction.

Authors:  S J Schleifer; M M Macari-Hinson; D A Coyle; W R Slater; M Kahn; R Gorlin; H D Zucker
Journal:  Arch Intern Med       Date:  1989-08

Review 5.  Major depression and physical illness. Special considerations in diagnosis and biologic treatment.

Authors:  S A Cohen-Cole; A Stoudemire
Journal:  Psychiatr Clin North Am       Date:  1987-03

6.  Major depressive disorder predicts cardiac events in patients with coronary artery disease.

Authors:  R M Carney; M W Rich; K E Freedland; J Saini; A teVelde; C Simeone; K Clark
Journal:  Psychosom Med       Date:  1988 Nov-Dec       Impact factor: 4.312

Review 7.  Use of cyclic antidepressants in patients with cardiac conduction disturbances.

Authors:  A Stoudemire; P Atkinson
Journal:  Gen Hosp Psychiatry       Date:  1988-11       Impact factor: 3.238

8.  Fluoxetine-induced bradycardia and syncope in two patients.

Authors:  J M Ellison; J E Milofsky; E Ely
Journal:  J Clin Psychiatry       Date:  1990-09       Impact factor: 4.384

Review 9.  Alprazolam as an antidepressant.

Authors:  M D Warner; C A Peabody; H A Whiteford; L E Hollister
Journal:  J Clin Psychiatry       Date:  1988-04       Impact factor: 4.384

10.  Mortality in patients with primary unipolar depression, secondary unipolar depression, and bipolar affective disorder: a comparison with general population mortality.

Authors:  D W Black; G Winokur; A Nasrallah
Journal:  Int J Psychiatry Med       Date:  1987       Impact factor: 1.210

View more
  1 in total

Review 1.  Psychiatric complications in the critically ill cardiac patient.

Authors:  K M Sanders; E H Cassem
Journal:  Tex Heart Inst J       Date:  1993
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.